Relationship between fibrosis and ventricular arrhythmias in Chagas heart disease without ventricular dysfunction
- PMID: 24918912
- PMCID: PMC4051448
- DOI: 10.5935/abc.20140052
Relationship between fibrosis and ventricular arrhythmias in Chagas heart disease without ventricular dysfunction
Abstract
Background: Patients with Chagas disease and segmental wall motion abnormality (SWMA) have worse prognosis independent of left ventricular ejection fraction (LVEF). Cardiac magnetic resonance (CMR) is currently the best method to detect SWMA and to assess fibrosis.
Objective: To quantify fibrosis by using late gadolinium enhancement CMR in patients with Chagas disease and preserved or minimally impaired ventricular function (> 45%), and to detect patterns of dependence between fibrosis, SWMA and LVEF in the presence of ventricular arrhythmia.
Methods: Electrocardiogram, treadmill exercise test, Holter and CMR were carried out in 61 patients, who were divided into three groups as follows: (1) normal electrocardiogram and CMR without SWMA; (2) abnormal electrocardiogram and CMR without SWMA; (3) CMR with SWMA independently of electrocardiogram.
Results: The number of patients with ventricular arrhythmia in relation to the total of patients, the percentage of fibrosis, and the LVEF were, respectively: Group 1, 4/26, 0.74% and 74.34%; Group 2, 4/16, 3.96% and 68.5%; and Group 3, 11/19, 14.07% and 55.59%. Ventricular arrhythmia was found in 31.1% of the patients. Those with and without ventricular arrhythmia had mean LVEF of 59.87% and 70.18%, respectively, and fibrosis percentage of 11.03% and 3.01%, respectively. Of the variables SWMA, groups, age, LVEF and fibrosis, only the latter was significant for the presence of ventricular arrhythmia, with a cutoff point of 11.78% for fibrosis mass (p < 0.001).
Conclusion: Even in patients with Chagas disease and preserved or minimally impaired ventricular function, electrical instability can be present. Regarding the presence of ventricular arrhythmia, fibrosis is the most important variable, its amount being proportional to the complexity of the groups.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures






Similar articles
-
Relationship between Urinary Norepinephrine, Fibrosis, and Arrhythmias in Chronic Chagas Heart Disease with Preserved or Mildly Reduced Ejection Fraction.Arq Bras Cardiol. 2022 Jul;119(1):3-11. doi: 10.36660/abc.20210400. Arq Bras Cardiol. 2022. PMID: 35830096 Free PMC article. English, Portuguese.
-
Associations between Cardiac Magnetic Resonance T1 Mapping Parameters and Ventricular Arrhythmia in Patients with Chagas Disease.Am J Trop Med Hyg. 2020 Aug;103(2):745-751. doi: 10.4269/ajtmh.20-0122. Epub 2020 May 14. Am J Trop Med Hyg. 2020. PMID: 32431281 Free PMC article.
-
Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.BMC Cardiovasc Disord. 2014 Aug 27;14:110. doi: 10.1186/1471-2261-14-110. BMC Cardiovasc Disord. 2014. PMID: 25160650 Free PMC article.
-
Electrocardiogram abnormalities in chronic Chagas cardiomyopathy correlate with scar mass and left ventricular dysfunction as assessed by cardiac magnetic resonance imaging.J Electrocardiol. 2022 May-Jun;72:66-71. doi: 10.1016/j.jelectrocard.2022.03.005. Epub 2022 Mar 21. J Electrocardiol. 2022. PMID: 35344746
-
Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):518-25. doi: 10.1093/ehjci/jes302. Epub 2013 Jan 16. Eur Heart J Cardiovasc Imaging. 2013. PMID: 23324829 Review.
Cited by
-
Pirfenidone Prevents Heart Fibrosis during Chronic Chagas Disease Cardiomyopathy.Int J Mol Sci. 2024 Jul 3;25(13):7302. doi: 10.3390/ijms25137302. Int J Mol Sci. 2024. PMID: 39000409 Free PMC article.
-
Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy.J Am Heart Assoc. 2019 Nov 19;8(22):e013365. doi: 10.1161/JAHA.119.013365. Epub 2019 Nov 13. J Am Heart Assoc. 2019. PMID: 31718442 Free PMC article.
-
The Presence and Extension of Myocardial Fibrosis in the Undetermined Form of Chagas' Disease: A Study Using Magnetic Resonance.Arq Bras Cardiol. 2018 Feb;110(2):124-131. doi: 10.5935/abc.20180016. Epub 2018 Feb 19. Arq Bras Cardiol. 2018. PMID: 29466491 Free PMC article.
-
The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.Arq Bras Cardiol. 2019 Mar;112(3):326-368. doi: 10.5935/abc.20190048. Arq Bras Cardiol. 2019. PMID: 30916199 Free PMC article. No abstract available.
-
Relationship between Urinary Norepinephrine, Fibrosis, and Arrhythmias in Chronic Chagas Heart Disease with Preserved or Mildly Reduced Ejection Fraction.Arq Bras Cardiol. 2022 Jul;119(1):3-11. doi: 10.36660/abc.20210400. Arq Bras Cardiol. 2022. PMID: 35830096 Free PMC article. English, Portuguese.
References
-
- Dias JC. Elimination of Chagas disease transmission: perspectives. Mem Inst Oswaldo Cruz. 2009;104(Suppl 1):41–45. - PubMed
-
- Dias JC, Prata A, Correia D. Problems and perspectives for Chagas disease control: in search of a realistic analysis. Rev Soc Bras Med Trop. 2008;41(2):193–196. - PubMed
-
- Rassi A, Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006;355(8):799–808. - PubMed
-
- Rassi A, Jr, Rassi JG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol. 2001;76(1):75–96. - PubMed
-
- Pazin-Filho A, Romano MM, Almeida OC, Filho, Furuta MS, Viviani LF, Schimidt A, et al. Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications. Braz J Med Biol Res. 2006;39(4):483–487. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical